NCT04926428View on ClinicalTrials.gov

In Situ Thrombolysis With tPA and Inflow Perfusion Analysis in Patient With Severe Covid-19 Infection

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 25, 2020

Primary Completion Date

March 30, 2021

Study Completion Date

March 30, 2021

Conditions
COVID-19
Interventions
DRUG

tPA

Selectively catheter thrombolysis with alteplase in each main pulmonary

Trial Locations (1)

06720

Hospital General de Mexico Dr Eduardo Liceaga, Mexico City

All Listed Sponsors
lead

Grupo Mexicano para el Estudio de la Medicina Intensiva

OTHER

NCT04926428 - In Situ Thrombolysis With tPA and Inflow Perfusion Analysis in Patient With Severe Covid-19 Infection | Biotech Hunter | Biotech Hunter